The sight of the ship defies logic: a 2,600-ton iron vessel situated in the middle of a neighbourhood in Banda Aceh, Indonesia. It once rested in the harbour, but was flung five kilometres inland by the devastating wall of water that hit the region almost 10 years ago.
Too massive to move, the former electric generator ship is now a memorial site that attracts tourists.
"You can climb to the top and barely see how far the ocean is off in the distance," said Dr. Lynda Redwood-Campbell, McMaster professor and coordinator of the Global Health Program within the Department of Family Medicine. "You realize the absolute strength of that tsunami."
Over the last decade she has travelled to the province of Aceh eight times to assist in recovery efforts. Now, as its 10th anniversary approaches on Dec. 26, Redwood-Campbell is reflecting on one of worst natural disasters that left more than 160,000 people dead.
McMaster University faculty are taking key roles in a new Network of Centres of Excellence (NCE) devoted to cancer research announced today by the Government of Canada.
They are involved in the Biotherapeutics for Cancer Treatment (BioCanRx) that will receive $25M from the federal government and an additional $35M from partners to investigate biotherapeutics, which hold potential to completely eliminate even advanced cancers with fewer side effects than current treatments.
Three researchers of the McMaster Immunology Research Centre are involved in the project:
- Brian Lichty, associate professor of pathology and molecular medicine, will lead the oncolytic viruses area of BioCanRx, and he is a member of its research management committee.
- Yonghong Wan, professor of pathology and molecular medicine, is a project leader for BioCanRx.
- Jonathan Bramson, professor of pathology and molecular medicine, will work with the team developing diagnostic tools to measure the activity of these novel therapies in patients.